01 November 2005
Clinicopathological Features of Lupus Anticoagulant: Experience at AFIP During Last Seven Years
Muhammad Ayyub, M Khan, Masood Anwar, Amin Waqar, Waqar Ali, Tassawar Hussain, Muhammad Luqman, Nadira Sultana, Karamat Karamat, Wasif SaifMed Sci Monit 2005; 11(11): CR536-539 :: ID: 430368
Abstract
Background: The lupus anticoagulant (LA) belongs to family of immunoglobulins,most commonly an IgG isotype. These antibodies have been identified most frequently in association withthromboembolic events, recurrent fetal loss and thrombocytopenia. The aim of the present study was toevaluate the presenting clinical and pathological features in patients LA positive presenting at AFIPRawalpindi over the period of Jan 1993 to Nov 2000. Material/Methods: Retrospective analysis of patientspresenting with positive LA was carried out. Results: 1583 suspected cases were screened for LA including1370 females and 213 males. 1024 cases presented with history of recurrent abortions, 292 with thrombosis,152 with thrombotic strokes before the age of 45 years, 52 with thrombocytopenia and 63 with miscellaneousdisorders. Out of 1024 patients tested for recurrent abortions, 130 (13%) females were positive for lupusanticoagulant. Ten (6.5%) of 152 patients presenting with strokes were found positive. Out of 292 casespresenting with thrombosis 17 (5.9%) were found positive. Conclusions: The lupus anticoagulant prevalencein Pakistani patients with recurrent fetal loss, stroke and thrombosis is statistically significant.Clinicians should be made aware of association of LA with various diseases. The successful managementof these patients depends upon close liaison with obstetricians, physicians and haematologists.
Keywords: Antiphospholipid Syndrome - diagnosis, Abortion, Habitual - immunology, Lupus Coagulation Inhibitor - analysis, Pregnancy, Stroke - immunology, Thromboembolism - immunology
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952